Prosthetic biologic valve endocarditis caused by a vancomycin-resistant (vanA) Enterococcus faecalis: Case report

Journal of Chemotherapy

Volumn 12, Issue 5, 2000, Pages 416-420

  Carfagna, P ^a   Tarasi, A ^a   Cassone, M ^a   Del Grosso, M F ^a   Blanco, G ^a   Venditti, M ^a  

^a Dipartimento di Medicina Clinica   (Italy)

Author keywords

Endocarditis; Enterococcus faecalis; Enterococcus faecium; Glycopeptide resistance; Vancomycin resistance

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; GENE PRODUCT; TEICOPLANIN; UNCLASSIFIED DRUG; VANA PROTEIN; VANCOMYCIN;

ABDOMINAL PAIN; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BIOPROSTHESIS; CASE REPORT; CHILL; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIARRHEA; DILUTION; ENTEROCOCCUS FAECALIS; FEVER; FOLLOW UP; GRAFT INFECTION; HEART VALVE PROSTHESIS; HISTOLOGY; HUMAN; MALE; MITRAL VALVE DISEASE; SYMPTOM; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 0033766440     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.5.416     Document Type: Article

References (26)

1. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993
2. Nosocomial bloodstream infections in United States Hospitals: A three-year analysis
3. Multidrug resistant enterococci and the threat of vancomycin-resistant Staphylococcus aureus
4. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC)
5. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
6. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
7. Epidemiological analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci
8. Outbreak of vancomycin-, ampicillin-, and aminoglyciside-resistant Enterococcus faecium bacteremia in an adult oncology unit
9. Outbreak of multi-drug resistant Enterococcus faecium with transferable van-B class vancomycin resistance
10. Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart
11. Prosthetic valve endocarditis caused by a vancomycin-resistant Enterococcus faecalis
12. Antibiotic-resistant endocarditis in a hemodialysis patient
13. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with vanA/vanB resistance patterns
14. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: A synergistic drug combination
15. Antimicrobial susceptibilities of enterococci isolated from hospitalized patients
16. Epidemiology of vanconycin-resistant enterococci in the community and the relevance of farm animals to human infection
17. The life and times of the enterococcus
18. Two-step acquisition of resistance to teicoplanin-gentamicin combination by van-B type Enterococcus faecalis in vitro and in experimental endocarditis
19. Quinupristin/dalfopristin: A new therapeutic alternative for the treatment of vancomycin-resistant Enterococcus faecium and other serious Gram-positive infections
20. Vancomycin susceptibility in enterococcal blood isolates in Italy: A multicenter retrospective analysis
21. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy
22. Enterococcal endocarditis. A comparison of prosthetic and native valve disease
23. Activity of new semisynthetic glycopeptides against vancomycin resistant organism
24. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin
25. Activities of new oxazolidinone antimicrobials against enterococci